Topic 1 - Coronary Heart Disease in Women Improving Outcomes Through Better Diagnosis and Treatment Original Airdate: January 12, 2007 Expiration date: January 2008 Note: This program no longer offers credits but is still available for review. Login or register now to access the archive of this activity.

Purpose Provide further understanding to physicians involved in the care of women with coronary heart disease (CHD) by exploring current evidence in diagnosis and treatment. Target Audience This activity meets the educational needs of physicians involved in the care of women with CHD. Program Overview Cardiologists diagnose, treat, and monitor patients with CHD every day, but each case and situation is unique to the circumstance and the patient. Women have different presenting symptoms than men and often fail to recognize symptoms of CHD. Awareness of new information specific to women has the potential to improve outcomes in women with CHD. This program will be presented by 3 thought leaders in the field of women's cardiology, who will discuss current diagnosis and treatment, as well as the ways to remove the barriers to improving outcomes in women with CHD. Educational Objectives Upon completion of this activity, participants should be better able to: Review guidelines for coronary prevention in women Predict which diagnostic techniques are best suited for women Describe the (misnamed) "atypical" presentations of CHD in women Understand the data about stable/CHD/angina pectoris in women Describe the outcomes of elective revascularization (PCI/CABG) in women

Agenda Welcome and Introduction Nanette K. Wenger, MD, FACC, FAHA, MACP, Chair Professor of Medicine, Division of Cardiology Emory University School of Medicine Chief of Cardiology Grady Memorial Hospital Atlanta, Georgia Prevention Guidelines Vera Bittner, MD, MSPH, FACC Professor of Medicine Division of Cardiovascular Disease University of Alabama at Birmingham Director Cardiac Rehabilitation Program University Hospital Birmingham, Alabama Diagnostic Modalities Vera Bittner, MD, MSPH, FACC CAD/Stable Angina Nanette K. Wenger, MD, FACC, FAHA, MACP, Chair Elective Revascularization (PCI/CABG) Alexandra J. Lansky, MD, FACC Associate Professor, Clinical Medicine Columbia University College of    Physicians and Surgeons Director Clinical Services Center for Interventional Vascular Therapy New York-Presbyterian Hospital/ Columbia University Medical Center New York, New York Question and Answer Alexandra J. Lansky, MD, FACC Closing Remarks Nanette K. Wenger, MD, FACC, FAHA, MACP, Chair